Ranger Investment Management L.P. bought a new position in Stevanato Group S.p.A. (NYSE:STVN – Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 1,186,375 shares of the company’s stock, valued at approximately $21,438,000. Stevanato Group makes up 1.4% of Ranger Investment Management L.P.’s portfolio, making the stock its 29th biggest holding. Ranger Investment Management L.P. owned approximately 0.39% of Stevanato Group at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. GW&K Investment Management LLC grew its holdings in shares of Stevanato Group by 76.2% in the fourth quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock valued at $49,000 after acquiring an additional 1,055 shares in the last quarter. Fifth Third Bancorp increased its position in shares of Stevanato Group by 22.6% during the 1st quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock valued at $58,000 after purchasing an additional 773 shares during the last quarter. State of Wyoming raised its stake in shares of Stevanato Group by 39,216.7% during the 2nd quarter. State of Wyoming now owns 2,359 shares of the company’s stock worth $58,000 after purchasing an additional 2,353 shares during the period. Quantbot Technologies LP bought a new stake in shares of Stevanato Group during the 3rd quarter worth $68,000. Finally, Tower Research Capital LLC TRC raised its stake in shares of Stevanato Group by 1,268.7% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,585 shares of the company’s stock worth $112,000 after purchasing an additional 4,250 shares during the period.
Stevanato Group Stock Performance
Shares of STVN stock opened at €22.60 on Monday. The firm’s 50 day moving average is €19.48 and its 200 day moving average is €17.27. The stock has a market capitalization of $6.84 billion, a P/E ratio of 40.36, a PEG ratio of 1.85 and a beta of 0.77. Stevanato Group S.p.A. has a 12 month low of €12.89 and a 12 month high of €28.00. The company has a current ratio of 1.61, a quick ratio of 1.08 and a debt-to-equity ratio of 0.21.
Insider Activity at Stevanato Group
In other news, Director William J. Federici sold 1,493 shares of the stock in a transaction dated Monday, June 15th. The shares were sold at an average price of €17.09, for a total value of €25,515.37. Following the sale, the director directly owned 26,991 shares of the company’s stock, valued at approximately €461,276.19. This represents a 5.24% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Lago Marco Dal sold 4,209 shares of the stock in a transaction dated Friday, August 7th. The stock was sold at an average price of €20.09, for a total transaction of €84,558.81. Following the completion of the sale, the chief financial officer directly owned 81,144 shares in the company, valued at approximately €1,630,182.96. The trade was a 4.93% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 14,249 shares of company stock worth $268,346 in the last 90 days.
Wall Street Analyst Weigh In
Several brokerages have commented on STVN. TD Cowen raised shares of Stevanato Group to a “strong-buy” rating in a research report on Wednesday, June 17th. Weiss Ratings raised shares of Stevanato Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 16th. Finally, Wolfe Research initiated coverage on Stevanato Group in a research note on Tuesday, June 2nd. They issued an “outperform” rating and a $21.00 price objective on the stock. Two investment analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, Stevanato Group presently has an average rating of “Buy”.
Read Our Latest Stock Report on STVN
About Stevanato Group
Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.
In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.
See Also
- Five stocks we like better than Stevanato Group
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding STVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stevanato Group S.p.A. (NYSE:STVN – Free Report).
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
